By Aneesh Garg, DO, CAQ · Double Board-Certified Sports Medicine Physician · Medical Director, American Shockwave Training Institute · Team Physician, USA Hockey and U.S. Soccer
The DART Lab is the Dynamic Athlete Research and Training Lab in Boulder, Colorado. It curates the peer-reviewed evidence behind the clinic’s five protocols, publishes our most-read clinical articles, prepares case reports from the practice, and houses the teaching work of Dr. Aneesh Garg, DO, CAQ, founder of the American Shockwave Training Institute, who trains other clinicians in the methods used here. Every study on this page is a real, citable publication in a named journal.
Regenerative medicine is full of claims. This page is the opposite: the actual studies, graded honestly, the articles we wrote to explain them, and the credentials of the physician who reads them. Use it to check our reasoning, or anyone else’s.
Insurance accepted for consultations. Cherry Technologies payment plans available. No pressure, honest assessment of whether we can help.
A clinic that teaches a method has to hold itself to the standard it teaches. Dr. Garg trains clinicians and physicians in focused shockwave therapy through ASTI. That teaching role is why this page exists: the literature we hand to course participants is the same literature this library curates for patients.
The library also says plainly what most clinic pages will not: which evidence is strong, which is still developing, and which is ours versus independent. Where a technology is newer, this page says so.
Every protocol at Dynamic Athlete traces to published evidence, and this library shows the receipts. The studies below are independent, peer-reviewed publications: we did not run them, and we do not pretend we did. What is ours is the clinical judgment built on them: which technologies to adopt, at what dose, on which equipment, for which patients.
Dr. Garg is the founder of the American Shockwave Training Institute (ASTI), where clinicians and physicians learn focused shockwave therapy on Storz Medical systems, and he serves as teaching faculty at the Regenerative Medicine Training Institute and Rocky Vista University. The training half of the DART Lab is that work: the standard taught to other clinics is the standard practiced here.
The articles below are the clinic’s most-read clinical explainers, written by Dr. Garg to answer the questions patients actually ask: why a treatment fails, how dose changes outcomes, what the cell evidence really says. Case reports from the practice are being prepared for publication and will be listed here as each is completed, with its status stated plainly.
Fifteen peer-reviewed publications, three for each of the five Dynamic protocols, selected and read by the physician who performs the procedures. Randomized trials, systematic reviews, and Cochrane analyses: named journals, named authors, real citations.
Three publications per protocol, chosen for quality and relevance. Tags mark the study type: Randomized Trial, Systematic Review, Guideline, Prospective / Clinical Study, Mechanism / Early
Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database Systematic Review
Schmitz C, et al. · British Medical Bulletin · 2015 · 116:115-138
A systematic review of randomized controlled trials in the PEDro physiotherapy database, concluding ESWT is an effective and safe option across a range of orthopedic conditions.
Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis Randomized Trial
Gollwitzer H, et al. · The Journal of Bone and Joint Surgery · 2015 · 97:701-708
A randomized, placebo-controlled multicenter trial in chronic plantar fasciitis: focused ESWT produced clinically relevant improvement in pain and function versus placebo.
Extracorporeal Magnetotransduction Therapy as a New Form of Electromagnetic Wave Therapy: From Gene Upregulation to Accelerated Matrix Mineralization in Bone Healing Mechanism / Early
Gerdesmeyer L, et al. · Biomedicines · 2024 · 12:2269
A laboratory study of how EMTT works at the cellular level in bone healing. EMTT’s clinical literature is newer and still growing; we label it accordingly rather than oversell it.
Dose and Composition of Platelet-Rich Plasma: A Systematic Review of Reporting in Clinical Trials Systematic Review
Chahla J, et al. · The Journal of Bone and Joint Surgery . 2017 · 99:1769-1779
A systematic review showing most PRP trials do not report what was actually injected: dose and composition vary widely between preparations. This is why “PRP” results differ so much between clinics, and why our protocol specifies dose.
Platelet Concentration and Its Effect on the Clinical Outcomes of Platelet-Rich Plasma Therapy Systematic Review
Berrigan WA, et al. · Orthopaedic Journal of Sports Medicine · 2024 · 12
A review of the relationship between platelet concentration and clinical outcome, supporting higher-dose preparations in knee osteoarthritis. The dose question is central to how Dynamic PRP+ is prepared: high-dose, multi-spin, over 10 billion platelets.
Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients Randomized Trial
Mishra AK, et al. · American Journal of Sports Medicine . 2014 · 42:463-471
One of the largest PRP trials in tendinopathy: 230 patients with chronic tennis elbow, with the PRP group showing significantly greater pain improvement at 24 weeks.
Mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials Systematic Review
Ma W, et al. · Journal of Orthopaedic Surgery and Research · 2020 · 15:431
A meta-analysis of randomized trials of mesenchymal cell therapy in knee osteoarthritis, finding improvements in pain and function versus controls.
Two-year clinical outcomes of autologous microfragmented adipose tissue in elderly patients with knee osteoarthritis Prospective / Clinical Study
Gobbi A, et al. · International Orthopaedics · 2021 · 45:1179-1188
A multicenter international study of MFAT in knee osteoarthritis showing durable improvement at two years, including in older patients.
Bone marrow aspirate concentrate is equivalent to platelet-rich plasma for the treatment of knee osteoarthritis at 2 years Randomized Trial
Anz AW, Andrews JR, et al. · American Journal of Sports Medicine · 2022 · 50:618-629
A prospective randomized trial from the Andrews research group comparing BMAC and PRP head to head in knee osteoarthritis: equivalent outcomes at two years. Cell source selection is a clinical decision, which is why Dynamic Stem Cell+ is physician-selected per patient.
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Randomized Trial
O’Reardon JP, et al. · Biological Psychiatry 2007 · 62:1208-1216
The multisite sham-controlled trial behind TMS’s original FDA clearance pathway in depression: active TMS outperformed sham on standard depression measures.
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial Randomized Trial
George MS, et al. · Archives of General Psychiatry · 2010 · 67:507-516
An NIH-funded sham-controlled trial confirming significantly higher remission rates with active TMS in medication-resistant depression.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018) Guideline
Lefaucheur JP, et al. · Clinical Neurophysiology · 2020 · 131:474-528
The international expert guideline assigning rTMS its evidence grades by indication, including Level A evidence in depression. EXOMIND is an FDA-cleared, drug-free TMS device; the guideline literature is the context it sits in.
Safety and efficacy of a non-invasive high-intensity focused electromagnetic field (HIFEM) device for treatment of urinary incontinence Prospective / Clinical Study
Samuels JB, et al. · Lasers in Surgery and Medicine · 2019 · 51:760-766
A clinical study of the HIFEM technology used in EMSELLA, reporting improvement in urinary incontinence and quality of life.
Electromagnetic stimulation for the treatment of stress urinary incontinence in women: a systematic review Systematic Review
Sun J, et al. · International Urogynecology Journal · 2023 · 34:327-339
A systematic review of electromagnetic stimulation for stress urinary incontinence, summarizing the trial evidence across devices and protocols.
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women Systematic Review
Dumoulin C, et al. · Cochrane Database of Systematic Reviews · 2018 · CD005654
The Cochrane review establishing that strengthening the pelvic floor works. It is the evidence base for the whole category: strengthening the pelvic floor is what the technology in Dynamic Core+ automates and intensifies.
Strongest evidence: focused ESWT in tendinopathy and plantar fasciitis, TMS in depression, pelvic floor strengthening for incontinence, and PRP in knee osteoarthritis and tennis elbow at adequate dose. Promising and developing: EMTT (mechanism established, clinical trials growing) and cell therapy comparisons (BMAC versus MFAT selection remains a clinical judgment). A page that grades everything “excellent” is marketing. This one is not.
Written by Dr. Garg. One per protocol, led by our most-read, these are the pages readers find when they ask the hard questions.
The most-read article on the site. Why “shockwave” that fails is usually radial pressure wave, not true focused ESWT, and what the ISMST/ASMST classification actually says.
The three variables that separate PRP that works from PRP that does not: platelet dose, image-guided placement, and the rehab that follows.
What the head-to-head literature says about bone marrow versus adipose cell sources, and why the choice is still a per-patient clinical decision.
The TMS evidence base behind EXOMIND, what FDA clearance does and does not mean, and who is a realistic candidate
What the HIFEM literature supports beyond incontinence, and why the clinic never administers EMSELLA alone.
The clinic tracks outcomes on every protocol. In our combined protocols, over 90% of our patients self-report a 75% or greater improvement, all without surgery. Formal case reports, structured and de-identified writeups of individual courses of care, are being prepared from that clinical experience.
This section will list each case report as it is completed, with its status stated plainly. We would rather show an honest “in preparation” than an invented result. Until then, the closest public record of how the clinic reasons through real presentations is the podcast below, where Dr. Garg walks through conditions case by case.
Double board-certified: Sports Medicine and Internal Medicine
Through the American Shockwave Training Institute, Dr. Garg trains clinicians and physicians in focused shockwave therapy on Storz Medical systems, aligned with ISMST and ASMST standards. Through The Regen Doc Podcast, he does the same for patients: seventeen episodes that walk through the conditions this clinic treats, including frozen shoulder, tennis elbow, rotator cuff tears, and why PRP sometimes fails.
Nothing appears here unless it is a real, documented course of care, de-identified, written up, and approved by Dr. Garg. No composite patients. No implied guarantees. Individual results vary, and case reports describe individual patients, not averages.
We have answered the most common questions about Dynamic PRP+, including how our multi-spin FRP system differs from standard PRP, which conditions respond best, what recovery looks like for athletes, how PRP integrates with shockwave priming, and what our patients experience. Our complete FAQ covers 53 questions with real patient outcomes and clinical detail you will not find elsewhere.
Across PRP, Stem Cell, Shockwave, EXOMIND, and EMSELLA. Tracked across active adults, postpartum patients, athletes, and surgery-avoiders.
All Dynamic PRP+ and Dynamic Stem Cell+ procedures are performed exclusively by Dr. Garg. Dynamic Shockwave+, Dynamic Mind+, and Dynamic Core+ are performed by Dr. Garg and his clinical team.
Aneesh Garg, DO, CAQ. Founder of Dynamic Athlete Sports Medicine and Regenerative Orthopaedics. Yale residency trained. Andrews Sports Medicine fellowship trained. Double board-certified Sports Medicine and Internal Medicine. Team Physician USA Hockey and U.S. Soccer. Founder and Medical Director of ASTI (American Shockwave Training Institute).
Teaching faculty RMTI and Rocky Vista University. Host of The Regen Doc podcast. Dr. Garg developed the Dynamic PRP+, Dynamic Stem Cell+, Dynamic Shockwave+, Dynamic Mind+, and Dynamic Core+ protocols used at this practice.
Yale residency trained. Andrews Sports Medicine fellowship trained. Double board-certified Sports Medicine and Internal Medicine.
Yale-New Haven Hospital residency
Fellowship-trained at the American Sports Medicine Institute (ASMI) / Andrews Sports Medicine
Team Physician for USA Hockey and U.S. Soccer
Medical Director of the American Shockwave Training Institute (ASTI), training clinicians nationwide in ESWT, RPW, and EMTT
Known for physician-performed, ultrasound-guided PRP, BMA/MFAT, and shockwave-primed biologic injections
The Regen Doc breaks down real patient cases, protocol design, and what actually works vs. what the industry sells. New episodes on Apple Podcasts, Spotify, and wherever you get your podcasts.
Talk with our team about whether you're a candidate. Care is directed by Aneesh Garg, DO, CAQ, here in Boulder.
Request a consult No obligation. We'll help you understand your options.